These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 37717726)
1. Verrucous venous malformation and lymphatic malformation, former similar phenotypes where cell-free DNA could clarify in genotype. Sun Y; Su L; Wang D; Fan X; Cai R J Am Acad Dermatol; 2024 Jan; 90(1):e27-e28. PubMed ID: 37717726 [No Abstract] [Full Text] [Related]
2. Verrucous Hemangioma or Verrucous Venous Malformation? Towards a Classification Based on Genetic Analysis. Knöpfel N; Hoeger PH Actas Dermosifiliogr; 2016 Jun; 107(5):427-8. PubMed ID: 26703822 [No Abstract] [Full Text] [Related]
3. Verrucous hemangioma (also known as verrucous venous malformation): A vascular anomaly frequently misdiagnosed as a lymphatic malformation. Boccara O; Ariche-Maman S; Hadj-Rabia S; Chrétien-Marquet B; Frassati-Biaggi A; Zazurca F; Brunelle F; Soupre V; Bodemer C; Fraitag S Pediatr Dermatol; 2018 Nov; 35(6):e378-e381. PubMed ID: 30216519 [TBL] [Abstract][Full Text] [Related]
4. Update on classification and diagnosis of vascular malformations. McCuaig CC Curr Opin Pediatr; 2017 Aug; 29(4):448-454. PubMed ID: 28654575 [TBL] [Abstract][Full Text] [Related]
5. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy. Palmieri M; Di Sarno L; Tommasi A; Currò A; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Fallerini C; Arzini A; Pinto A; Vaghi M; Renieri A J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):740-744. PubMed ID: 32858245 [TBL] [Abstract][Full Text] [Related]
6. Comment on "Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study": Are we missing the lymphatic malformation component? Cai R; Yang X; Gu H; Chen H; Lin X J Am Acad Dermatol; 2023 Mar; 88(3):e133-e134. PubMed ID: 30240774 [No Abstract] [Full Text] [Related]
7. Reply to "Comment on 'Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study': Are we missing the lymphatic malformation component?". Chen H; Zhang G J Am Acad Dermatol; 2023 Mar; 88(3):e135-e136. PubMed ID: 30240777 [No Abstract] [Full Text] [Related]
11. Vascular anomalies of the head and neck: a review of genetics. Yadav P; De Castro DK; Waner M; Meyer L; Fay A Semin Ophthalmol; 2013; 28(5-6):257-66. PubMed ID: 24010650 [TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of verrucous hemangiomas. Trindade F; Torrelo A; Requena L; Tellechea O; Del Pozo J; Sacristán F; Esteve-Martínez A; de Unamuno B; de Miquel VA; Colmenero I J Cutan Pathol; 2013 May; 40(5):472-6. PubMed ID: 23578182 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series. Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593 [TBL] [Abstract][Full Text] [Related]
19. [Non-syndromic cutaneous vascular malformations]. Barreau M; Dompmartin A Ann Dermatol Venereol; 2014 Jan; 141(1):56-67. PubMed ID: 24461098 [No Abstract] [Full Text] [Related]
20. Verrucous venous malformations of the hand. Beijnen UEA; Saldanha F; Ganske I; Upton J; Taghinia AH J Hand Surg Eur Vol; 2019 Oct; 44(8):850-855. PubMed ID: 31042103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]